Crossmark

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis

Crossref DOI link: https://doi.org/10.1007/s12325-022-02376-y

Published Online: 2022-12-19

Published Print: 2023-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fox, David https://orcid.org/0000-0002-5465-1648
To, Tu My https://orcid.org/0000-0001-9506-7539
Seetasith, Arpamas https://orcid.org/0000-0003-0648-7764
Patel, Anisha M. https://orcid.org/0000-0003-1902-905X
Iannaccone, Susan T. https://orcid.org/0000-0003-0851-3516
Funding

Funding for this research was provided by:

Genentech
License Information

Text and Data Mining valid from 2022-12-19

Version of Record valid from 2022-12-19
More Information

Article History

Received: 9 June 2022

Accepted: 2 November 2022

First Online: 19 December 2022